ACADSB expression was significantly associated with pathological T stage (T1-2 vs. T3-4, P< 0.001; Figure 3A), pathological N stage (N0 vs. N1, P< 0.01; Figure 3B), pathological M stage (M0 vs. M1, P< 0.001; Figure 3C), pathological stage (stage I-II vs. stage III-IV, P< 0.001; Figure 3D), tumor grade (grades 1–2 vs. grades 3–4, P< 0.001; Figure 3E), tumor status (tumor free vs. with tumor, P< 0.001; Figure 3F), and sex (P< 0.01; Figure 3G). Here, ACADSB is linked to neoplasm.